Böcker i Contemporary Cardiology-serien

This book provides a comprehensive overview of the physiology, pathophysiology, diagnosis, medical and surgical management, and future therapies for tricuspid valve disease. It is divided into two sections. The first section covers the basics of the tricuspid valve, including anatomy, epidemiology, and clinical diagnosis with individual chapters focused on hemodynamics, echocardiography, MRI, and CT assessment. The second section examines current treatments for tricuspid valve disease including both surgical and medical management. It discusses special clinical scenarios of tricuspid valve pathology such as tricuspid regurgitation in patients with ICD and pacemaker implants and the role of tricuspid valve disease in patients with heart failure and LVAD therapy. Tricuspid Valve Disease: A Comprehensive Guide to Evaluation and Management is an essential resource for general cardiologists, interventional cardiologists, cardiac surgeons, and innovators in the field of structural heart disease. 

Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease. Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovascular events compared to people with low Lp(a) levels. Despite this risk, awareness of Lp(a) is still very low among health care providers. Even cardiologists often overlook Lp(a), in part because Lp(a) is not as well-understood as other risk factors and treatment options are still very limited. This book offers an authoritative and comprehensive overview of Lipoprotein(a). It provides an in-depth review of all aspects of Lp(a), from pathophysiology to metabolism. Chapters offer the reader a contemporary view of the important roles of Lp(a) as a risk factor for cardiovascular disease. In addition, this volume discusses the clinical implications of elevated Lp(a) and current and future therapies. Lipoprotein(a) is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.

This book examines new technologies (device and pharmacologic) that have evolved over the past few years in treating peripheral arterial disease. Chapters offer optimal strategies to treat PAD, supported by peer-reviewed data. The pillars of this strategy will focus on (a) changing vessel compliance to allow better lumen expansion, (b) less recoil and dissections, and (c) less bailout stenting. Chapters also review embolic protection devices and apply the adjunctive use of anti-proliferative therapy to maintain good long term outcomes. In addition, the book reviews drug coated balloons and drug eluting stent technologies and other means of drug delivery into the vessel wall. The goal of this book is to discuss all these emerging technologies under the strategy of treating patients with the focus on both acute and long term outcomes. Featuring world renown experts, this book offers a critical and comprehensive overview of the current data and future directions that would pave the way for optimal PAD management.Peripheral Arterial Interventions is an essential resource for physicians, residents, fellows, and medical students in cardiology, radiology, vascular surgery, primary care, and health promotion and disease prevention as well as internal and vascular medicine specialists.

Acute coronary syndrome (ACS) continues to challenge our health care system in the complexity of presentation and the ever increasing number of patients exhibiting signs and symptoms of an acute coronary syndrome. Written by leading experts, Short Stay Management of Chest Pain provides scientific and clinical insights on the management of patients who arrive at the hospital with a presentation consistent with a potential acute coronary syndrome. Focusing on the cardiology aspects of chest pain, Short Stay Management of Chest Pain is a valuable tool for acute care physicians, nurses, and hospital administrators devoted to caring for this population. Short Stay Management of Chest Pain details the remarkable improvements in diagnostic accuracy and improved patient outcomes for patients presenting with suspected acute coronary syndromes.

Cardiovascular heart disease mortality in African Americans is the highest of all major racial/ethnic subpopulations in the United States. Examining race and ethnicity, Cardiovascular Disease in Racial and Ethnic Minorities will reveal that there are unacceptable healthcare disparities in risk factor prevalence, disease states, and cardiovascular outcomes in the United States. Written by a team of experts, Cardiovascular Disease in Racial and Ethnic Minorities examines to what degree biomedical and scientific literature can clarify the impact of genetic variation versus environment as related to cardiovascular disease. Chapters illustrate the magnitude of cardiovascular and metabolic disparities and the effect of environment on diseases.

This book is the first comprehensive text dedicated to risk assessment in the primary prevention of atherosclerotic cardiovascular disease. It provides an overview of current evidence regarding approaches to risk assessment, traditional and emerging risk factors, and atherosclerosis imaging for refinement of risk estimation. The volume seeks to provide an essential resource for professionals in the field to assess their patients for risk of cardiovascular disease. The book is divided into five sections, starting off with an overview of current best practices to risk assessment in primary prevention around the world. The second section discusses traditional risk factors, such as hypercholesterolemia, hypertension, diabetes, smoking, and obesity. The third section reviews the newly introduced concept of 'Risk Enhancers'. The fourth section offers insight on novel risk factors, with in-depth discussion regarding lipoprotein(a), high-sensitivity CRP, apolipoprotein B, social determinants of health, stress and cardiovascular disease. and polygenic risk scores. The final section covers the use of non-invasive atherosclerosis imaging (computed tomography and ultrasound-based techniques) as a tool to refine risk estimates. Throughout the book, readers will find multiple tables, figures, and illustrations that complement the text. Up-to-date, evidence-based, and clinically oriented, Cardiovascular Risk Assessment in Primary Prevention is a must-have resource for physicians, residents, fellows, and medical students in cardiology, endocrinology, primary care, and health promotion and disease prevention.

This book provides an evidence-based approach for the clinical use of nutraceuticals in the prevention and management of cardiovascular disease. It examines cardiovascular disease epidemiology, risk factors, and the role of dietary patterns. Clinical chapters discuss the use of nutraceuticals in the management of medical conditions such as dyslipidemia, hypertension, insulin resistance, and heart failure. Each chapter contains a short epidemiological background; a list of relevant active compounds and their efficacy, tolerability, and safety; and suggestions for prescribers. This book is a practical guide with the best clinical evidence supporting the use of nutraceuticals in cardiology. Nutraceuticals and Cardiovascular Disease: An Evidence-based Approach for Clinical Practice is an essential resource for physicians, residents, fellows, and medical students in cardiology, clinical nutrition, dietetics, and internal medicine.

The second edition of this key resource provides a broad and fundamental overview of basic cardiovascular (CV) hemodynamic principles with a focus on clinical assessment of CV physiology.

This second edition provides an updated review on the current guidelines and practice standards for the clinical management of cardiovascular risk factors and prevention of cardiovascular diseases.

With a step-by-step method for accurate interpretation of the ECG, this third edition of Rapid ECG Interpretation describes a systematic approach consistent with the changes in cardiology practice over the past decade.

This timely volume addresses the areas of pathophysiology and therapy of pulmonary hypertension, which have seen exciting developments. Expert authors describe new therapies that have led to significant improvements in patient function and survival.

This book provides a road map for the efficient and successful management of atrial fibrillation (AF) in the short stay unit.

A path-breaking and comprehensive review of the pathophysiology and management of patients with acute coronary syndromes (ACS). Drawing on the key results of recent clinical trials, world-renowned clinicians and clinical investigators establish state-of-the-art management guidelines for patients with ST-elevation MI or non-ST-elevation ACS. Their discussion includes a detailed review of the pathophysiology of ACS and a survey of the diagnostic tools available to assess patients. Management of Acute Coronary Syndromes captures the major advances that have occurred in our understanding of the pathophysiology, diagnosis, and management of patients with acute coronary syndromes. This book is certain to help cardiologists, primary physicians, emergency medicine physicians, and many others to better serve their patients with today''s most efficacious treatments.

This book provides a road map for defining the care of acute heart failure (HF) patients in the short stay or observation unit setting.

The thoroughly updated second edition of this key textbook provides an authoritative discussion of cardiovascular disease for the practicing primary care clinician.

Leading interventional cardiologists, including Patrick Serruys, provide the gold-standard reference on the treatment of restenosis for interventional cardiologists.

Percutaneous left atrial appendage (LAA) closure is an emerging technology for thromboembolic prevention in patients with atrial fibrillation (AF). The first human implantation of an LAA device occurred in 2001, and since then four devices have received CE mark approval.

This important new book presents advancements in the treatment and prevention of Atrial Fibrillation (AF). Each chapter deals with a different aspect of AF and each chapter is authored by internationally recognized experts in the evolving field of cardiac electrophysiology.

Acute coronary syndrome (ACS) continues to challenge our health care system in the complexity of presentation and the ever increasing number of patients exhibiting signs and symptoms of an acute coronary syndrome.

Over the past three decades, carotid artery stenting has evolved to become a promising and viable alternative to carotid endarterectomy, especially for patients deemed to have high surgical risks.

This handbook supplements hands-on training in interventional cardiology with a specific focus on percutaneous intervention in patients with extracranial carotid artery stenosis. It carries reviews of landmark studies supporting carotid endarectomy and stenting and is a comprehensive guide to this exciting and burgeoning field.

Written by experts in the field, this book provides a comprehensive overview of the pathophysiology, including the genetics, of arterial and venous thrombosis. It also presents the evidence demonstrating the efficacy of available antithrombotic therapies.

This book provides a road map for the efficient and successful management of atrial fibrillation (AF) in the short stay unit.

This book provides a road map for defining the care of acute heart failure (HF) patients in the short stay or observation unit setting.

A comprehensive survey of nonsurgical treatment for a variety of heart diseases that affect the cardiac valves, the heart muscle, and the structure of the heart.